Profil
Kai Pinkernell is former Chief Medical Officer & Senior Vice President of MediGene AG, former Senior Director-Regenerative Cell Technology at Plus Therapeutics, Inc. and former Head-Global Clinical Business at Miltenyi GmbH.
He received an MBA from USC Marshall School of Business and a doctorate from the University of Münster.
Anciens postes connus de Kai Pinkernell
Sociétés | Poste | Fin |
---|---|---|
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Corporate Officer/Principal | 01/01/2016 |
MEDIGENE AG | Chief Tech/Sci/R&D Officer | - |
PLUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Kai Pinkernell
University of Münster | Doctorate Degree |
USC Marshall School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MEDIGENE AG | Health Technology |
PLUS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |